Vaccine News and Research

Latest Vaccine News and Research

Infants who get hepatitis C from mothers during childbirth may inherit viral strain

Infants who get hepatitis C from their mothers during childbirth may inherit a viral strain that replicates more quickly than strains found in non-pregnant hosts, according to a new study published Oct. 27 in Nature Medicine.

29 Oct 2013

African-American women less likely to benefit from HPV vaccines to prevent cervical cancer

Two subtypes of human papillomavirus prevented by vaccines are half as likely to be found in African-American women as in white women with precancerous cervical lesions, according to researchers at Duke Medicine.

29 Oct 2013

Study shows low uptake of HPV vaccination among patients with autoimmune diseases

The number of children and young adults with autoimmune diseases receiving the HPV vaccination is profoundly low despite studies showing the vaccine to be safe and effective, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego. Given the increased incidence of HPV in people with autoimmune diseases, this research suggests that increased public health efforts are needed.

28 Oct 2013

NHMRC awards over $6M for Griffith University research projects

Griffith University research projects have been awarded just over $6m in research funding by the prestigious National Health and Medical Research Council.

28 Oct 2013

Potentially active forms of HIV hiding in infected immune T cells may be 60-fold greater, say experts

Just when some scientists were becoming more hopeful about finding a strategy to outwit HIV's ability to resist, evade and otherwise survive efforts to rid it from the body, another hurdle has emerged to foil their plans, new research from Johns Hopkins shows.

25 Oct 2013

Study finds persistent deficiency in new therapeutics for neglected diseases

In a study published today in the open-access journal The Lancet Global Health, the Drugs for Neglected Diseases initiative and other researchers report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal progress and an acceleration in research and development efforts. This continued 'fatal imbalance' in medical R&D points to the urgent need to develop and deliver groundbreaking new treatments for the world's poorest and most neglected patients.

25 Oct 2013

HIV-positive patients with high CD4 cell counts are not at increased risk for heart attacks

Patients who are HIV-positive and have high CD4 cell counts - or have a high number of white blood cells that fight infections - aren't at an increased risk for heart attacks compared to patients who are HIV-negative, according to a Kaiser Permanente study that appears in the current online issue of the Journal of Acquired Immune Deficiency Syndromes.

25 Oct 2013

Merck provides overview of clinical trial program for HPV vaccine V503

Merck, known as MSD outside the United States and Canada, today provided an overview of the clinical trial program for V503, the company's investigational 9-valent human papillomavirus vaccine, to the Advisory Committee on Immunization Practices in the United States.

25 Oct 2013

Pertussis incidence: an interview with Leonard Friedland, M.D., V.P. and Director of Scientific Affairs and Public Health for GSK Vaccines

Distinguishing pertussis (also known as whooping cough) from other respiratory illnesses is challenging in particular among adults because the signs and symptoms of pertussis overlap with those of other respiratory diseases.

24 Oct 2013

Scientists find disparities in regulation of transposons between humans and non-human primate cells

Researchers at the Salk Institute for Biological Studies have, for the first time, taken chimpanzee and bonobo skin cells and turned them into induced pluripotent stem cells, a type of cell that has the ability to form any other cell or tissue in the body.

24 Oct 2013

Researchers identify potential way to combat TB

Researchers have identified a potential way to manipulate the immune system to improve its ability to fight off tuberculosis.

24 Oct 2013

State-of-the-art HIV vaccine laboratory opens in Cape Town, South Africa

Fred Hutchinson Cancer Research Center tomorrow will celebrate the grand opening of a state-of-the-art HIV vaccine laboratory in Cape Town, South Africa.

24 Oct 2013

BCG asthma effects are lost in adolescence

Any beneficial effects of the neonatal Bacillus Calmette–Guérin vaccine on childhood asthma symptoms and outcomes are likely to be transient, disappearing by adolescence, show follow-up findings from the Manchester Community Asthma Study.

23 Oct 2013

New flu vaccine offers better protection against circulating flu viruses

Last year's flu season was considered one of the strongest and deadliest in recent decades, according to the CDC. In preparation for this year's flu season, Concentra, a subsidiary of Humana Inc., offers a flu vaccine to provide greater protection against circulating flu strains.

23 Oct 2013

Cleveland Biolabs Subsidiary Awarded $4.6M Russian Contract

...

23 Oct 2013

Scientists create artificial protein that mimics key site on the outer coat of HIV

A team of scientists at Duke Medicine and Memorial Sloan-Kettering Cancer Center has created an artificial protein coupled with a sugar molecule that mimics a key site on the outer coat of HIV where antibodies can bind to neutralize a wide variety of HIV strains.

23 Oct 2013

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

The flu vaccine may not only ward off serious complications from influenza, it may also reduce the risk of heart attack or stroke by more than 50 per cent among those who have had a heart attack, according to new research led by Dr. Jacob Udell, a cardiologist at Women's College Hospital and clinician-scientist at the University of Toronto. What's more, the vaccine's heart protective effects may be even greater among those who receive a more potent vaccine.

23 Oct 2013

Influenza vaccination linked with reduced risk of adverse cardiovascular events

Receiving an influenza vaccination was associated with a lower risk of major adverse cardiovascular events such as heart failure or hospitalization for heart attack, with the greatest treatment effect seen among patients with recent acute coronary syndrome (ACS; such as heart attack or unstable angina), according to a meta-analysis published in the October 23/30 issue of JAMA.

23 Oct 2013

Study evaluates role of enteroviruses in human type 1 diabetes

Type 1 diabetes is a disease caused by the destruction of the insulin-producing cells in the pancreas. It is often diagnosed in childhood and requires life-long treatment with daily insulin injections. It is associated with an increased risk for long-term complications which decrease the quality of life and average life-expectancy.

23 Oct 2013

COPD treatments: an interview with Professor Price, University of Aberdeen

The first thing is that we can’t cure COPD. The problem we have with COPD is that the process itself is not treatable, certainly not once it gets to the extent that it’s advanced.

22 Oct 2013

Vaccine News and Research

Latest Vaccine News and Research

Infants who get hepatitis C from mothers during childbirth may inherit viral strain

African-American women less likely to benefit from HPV vaccines to prevent cervical cancer

Study shows low uptake of HPV vaccination among patients with autoimmune diseases

NHMRC awards over $6M for Griffith University research projects

Potentially active forms of HIV hiding in infected immune T cells may be 60-fold greater, say experts

Study finds persistent deficiency in new therapeutics for neglected diseases

HIV-positive patients with high CD4 cell counts are not at increased risk for heart attacks

Merck provides overview of clinical trial program for HPV vaccine V503

Pertussis incidence: an interview with Leonard Friedland, M.D., V.P. and Director of Scientific Affairs and Public Health for GSK Vaccines

Scientists find disparities in regulation of transposons between humans and non-human primate cells

Researchers identify potential way to combat TB

State-of-the-art HIV vaccine laboratory opens in Cape Town, South Africa

BCG asthma effects are lost in adolescence

New flu vaccine offers better protection against circulating flu viruses

Cleveland Biolabs Subsidiary Awarded $4.6M Russian Contract

Scientists create artificial protein that mimics key site on the outer coat of HIV

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

Influenza vaccination linked with reduced risk of adverse cardiovascular events

Study evaluates role of enteroviruses in human type 1 diabetes

COPD treatments: an interview with Professor Price, University of Aberdeen

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in